Teva Pharmaceuticals’ Motion to Dismiss Denied
On September 9, 2021, Judge Nathaniel Gorton of the United States District Court for the District of Massachusetts ruled against…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Monthly Archives
September 2021
Endo International Plc Reaches $50 Million Settlement with New York State…
On September 9, 2021, Endo International plc announced a settlement with New York state and two New York counties over its sale…
HHS OIG and DOJ Release Annual Report
Recently, the Annual Report of the Departments of Health and Human Services and Justice was released, highlighting health care…
CBO Simulates the Elijah E. Cummings Lower Drug Costs Now Act
The Congressional Budget Office (CBO) recently released a Simulation Model of New Drug Development that mimicked the Elijah E.…
OPDP Sends Third Untitled Letter of the Year to Eton Pharmaceuticals
On August 9, 2021, the United States Food and Drug Administration (FDA) Office of Prescription Drug Promotion (OPDP) sent its…
FDA Reconsidering the Need for Mandatory Opioid Prescriber Education
Recently, the United States Food and Drug Administration (FDA) announced a public workshop to discuss mandatory prescriber…
Sutter Health Reaches $90 Million Settlement Over Alleged False Claims Act…
On August 30, 2021, the United States Department of Justice announced that Sutter Health, a California-based health care provider,…
Fifth Circuit Court of Appeals Allows Government to Dismiss FCA Cases…
Earlier this summer, a three-judge panel of the the United States Court of Appeals for the Fifth Circuit found in favor of the…
Telemedicine Fraud Scheme Results in Civil and Criminal Enforcement Actions…
On August 24, 2021, the United States Department of Justice announced civil and criminal enforcement actions against several…
Alternative Drug Pricing Legislation Introduced by Moderate Democrats
Centrist Democrats in the United States House of Representatives are working on introducing an alternate approach to drug pricing…